Administered as a once-weekly subcutaneous injection, tirzepatide works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, thereby improving glycaemic control
Only for Licensed Professionals David Fuller Last Updated On: September 10, 2024 According to a recent study, side effects associated with diabetes type 2 medications can significantly impact patients quality of life
Selective regulation does not eliminate risk
Regular monitoring helps identify patterns after meals, fasting periods, dose changes, and changes in diet or activity
Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials
Fermented foods can initially increase gas before the beneficial bacterial populations establish themselves